Feedback

Louisiana Department of Health & Hospitals | Kathy Kliebert, Secretary

PrintRSSShareTwitterFacebookWordPressYouTube
Statewide Initiatives



211 - Get Connected. Get Answers.

Antibiotic Sensitivity - Program

History

The Emerging Pathogens Active Surveillance System commenced five years ago in an attempt to track the emergence of antibiotic resistant organisms. This federally funded surveillance program allows Louisiana to be part of a nationwide project to track and evaluate antibiotic resistant trends. Our surveillance system monitors three pathogens: Methicillin resistant Staphylococcus aureus (MRSA), drug resistant Streptococcus pneumoniae (DRSP), and Vancomycin resistant enterococcus (VRE).

Mission and Vision

The mission of the Emerging Pathogens Active Surveillance System is:

  1. To estimate the percent of selected bacteria in the state that are resistant to antibiotics, (MRSA, DRSP, and VRE) by the reporting of laboratory aggregate data.
  2. To describe the demographic characteristics of newly infected cases through the reporting of information as required by the Louisiana Sanitary Code, Chapter II, Section 2:003 and 2:004.

Primary Contact Information:

Antibiotic Sensitivity Program: Lauren Elmendorf, MPH
Address:
1450 Poydras Street, Ste 2162-B
New Orleans, LA 70112

Telephone: (504) 568-8318
Fax: (504) 568-8290
Email: lauren.elmendorf@la.gov